Zydus Cadila one crore doses pricing
Zydus Cadila one crore doses pricing. Drug Controller General (DCGI) of India approved Zydus Cadila for its emergency use for children aged 12 years or above. It is produced in association with the Department of Biotechnology. Bharat Biotech’s Covaxin is the second homegrown vaccine that got approval for EUA. The company said that it will produce one crore doses per month by October but it will not be able to produce 5 crore doses in August to meet the government’s commitment. The Company will produce 3-5 crore doses by December -January. The Price of the vaccine will be announced in a couple of months. It is the world’s first DNA-based vaccine and it is needle-free which will help to reduce side effects.